ABBV vs EW
By Alex · Tickerpine
AbbVie Inc. vs Edwards Lifesciences Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | EW |
|---|---|---|
| Price | $285.64 | $89.07 |
| Market cap | $504.76B | $51.34B |
| P/E ratio | 80.5 | 53.0 |
| ROE | — | 9.18% |
| Profit margin | 9.80% | 15.43% |
| Revenue growth | 10.20% | 13.60% |
| Dividend yield | 2.42% | 0.00% |
| Beta | 0.23 | 0.86 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs EW in plain English
- ABBV is the bigger company — about 9.8× the market cap of EW.
- EW is cheaper on earnings (P/E 53.0 vs 80.5).
- EW is growing revenue faster (14% vs 10%).
- ABBV pays a dividend (2.42%) while the other effectively doesn't.
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
EW return calculator
See what $1,000 in Edwards Lifesciences Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.